ArticleMolecular plant pathology2026
FgCot1 Regulates Polarized Growth and Conidiation in Fusarium graminearum via Gpmk1 MAPK and Tsf1 Transcriptional Pathways.
Article in Molecular plant pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Fusarium graminearum causes Fusarium head blight (FHB), a devastating wheat disease that threatens global food security and safety. Nuclear Dbf2-related (NDR) kinases regulate cellular morphogenesis, but their roles in phytopathogenic fungi remain elusive. Here, we characterized F. graminearum NDR kinase FgCot1, whose deletion severely disrupted vegetative growth, conidiation, polarized growth and pathogenicity. Notably, the Fgcot1 mutant showed genetic instability, producing fast-growing suppressors with primary (Gpmk1 pathway genes), secondary (MFS transporter SSF1) and tertiary (transcription factor TSF1) mutations. Functional analyses revealed that disrupting the Gpmk1 pathway partially rescued the Fgcot1 growth defects due to Gpmk1 hyperactivation, whereas SSF1 deletion independently enhanced growth. The TSF1
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.